FemBloc® Permanent Contraception - Confirmation Feasibility Trial

NCT ID: NCT04273594

Last Updated: 2025-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-27

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The trial objectives include evaluating the adequacy of proposed mitigations for the previous pivotal trial of the FemBloc Permanent Contraceptive System and validating the confirmation procedure by comparing FemChec (ultrasound) to fluoroscopic hysterosalpingogram (fluoro HSG) for post-occlusion in the same patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FemBloc

Investigational device and procedure

Group Type EXPERIMENTAL

FemBloc

Intervention Type DEVICE

Treatment with FemBloc for women who desire permanent birth control (female sterilization)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FemBloc

Treatment with FemBloc for women who desire permanent birth control (female sterilization)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female, 21 - 45 years of age desiring permanent birth control
* Sexually active with male partner
* Regular menstrual cycle for last 3 months or on hormonal contraceptives

Exclusion Criteria

* Uncertainty about the desire to end fertility
* Known or suspected pregnancy
* Prior tubal surgery, including sterilization attempt
* Prior endometrial ablation
* Presence, suspicion, or previous history of gynecologic malignancy
* Abnormal uterine bleeding requiring evaluation or treatment
* Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)
* Allergy to shellfish, betadine or iodinated contrast
Minimum Eligible Age

21 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Femasys Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New Horizons Clinical Trials

Chandler, Arizona, United States

Site Status

Precision Trials AZ, LLC

Phoenix, Arizona, United States

Site Status

Midtown OB GYN North

Columbus, Georgia, United States

Site Status

Women's Health Advantage

Fort Wayne, Indiana, United States

Site Status

Saginaw Valley Medical Research Group

Saginaw, Michigan, United States

Site Status

University Hospitals - Cleveland Medical Center

Beachwood, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP-100-008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Simplified IUD Insertion Technique
NCT02733081 WITHDRAWN NA
Memory Gel and Shape Combined Cohort
NCT02919592 ACTIVE_NOT_RECRUITING NA